Dr. Reddys Labs (RDY) Receives Tentative FDA Approval for Zenavod as Rosacea Treatment
Go back to Dr. Reddys Labs (RDY) Receives Tentative FDA Approval for Zenavod as Rosacea TreatmentDR. REDDY'S LAB LTD ADR (NYSE: RDY) | Delayed: 71.31 -0.3 (0.42%) | |||||
---|---|---|---|---|---|---|
Previous Close | $71.61 | 52 Week High | $54.73 | |||
Open | $71.65 | 52 Week Low | $40.68 | |||
Day High | $71.71 | P/E | N/A | |||
Day Low | $71.19 | EPS | $0.00 | |||
Volume | 141,889 |